Nanoscale polymer antibodies efficiently target and eliminate cancer cells

Scientists have demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or 'plastic antibodies'. NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.